DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Stevanović J, de Jong LA, Kappelhoff BS, Dvortsin EP, Voorhaar M, Postma MJ.
Dabigatran for the treatment and secondary prevention of venous thromboembolism: a cost-effectiveness analysis for the Netherlands.
PLoS One 2016;
11 (10) e0163550
We do not assume any responsibility for the contents of the web pages of other providers.